Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 331 of 5804
-
New triple therapy aims to wipe out head and neck tumors before surgery
Disease control Not yet recruitingThis clinical trial aims to evaluate the efficacy and safety of Becotatug Vedotin (EGFR-Targeting ADC) in combination with Pucotenlimab and Cisplatin as neoadjuvant therapy for patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC). The primary objective…
Phase: PHASE2 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Blood test could detect Alzheimer's years before symptoms worsen
Diagnosis Not yet recruitingAlzheimer's disease is a degenerative condition affecting the brain and is the most common form of dementia in older adults. Dementia is currently a major healthcare issue in the UK, affecting approximately a million people. The progression of the disease varies between individua…
Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Could a shorter treatment be just as good for AML in the elderly?
Disease control Not yet recruitingThis study aims to compare the efficacy and safety of a shortened treatment course based on the bone marrow blast count on Day 14 versus standard treatment in patients with acute myeloid leukemia treated with venetoclax plus azacitidine.
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for NMOSD attacks: immune drug added to standard care
Disease control Recruiting nowThis project is a multi-center, prospective, real-world cohort study that collects clinical data of Chinese patients with AQP4-positive NMOSD in the acute stage. It comprehensively assesses the clinical outcomes of the patients and aims to compare the clinical efficacy and safety…
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart attack survivors: new study seeks safer, smarter drug plan after stents
Disease control Not yet recruiting" Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) require optimized medical therapy to prevent recurrent cardiovascular events. This includes both antiplatelet and lipid-lowering strategies. For antip…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New device could save lives by stopping severe bleeding in trauma patients
Disease control Not yet recruitingThis study seeks to evaluate the feasibility of a Abdominal Aortic Balloon Occlusion of the Aorta (AAJT-S) in exanguinating trauma patients with non-compressible truncal haemorrhage in the emergency room and the pre-hospital setting.
Sponsor: Medical University of Graz • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo aims to cut transfusions for blood disorder patients
Disease control Recruiting nowβ-thalassemia is one of the most common inherited hemoglobinopathies worldwide and a major public health issue that severely impacts birth quality, human health, and social progress. Currently, there are limited clinical drugs specifically designed to treat patients with β-thalas…
Phase: PHASE2 • Sponsor: Rongrong Liu • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could steroids beat a deadly lung virus? new trial aims to find out
Disease control Not yet recruitingSevere community-acquired pneumonia caused by adenovirus (hereafter referred to as severe adenovirus pneumonia) is one of the common forms of severe community-acquired pneumonia in immunocompetent adults. It predominantly affects young individuals, progresses rapidly, and is asso…
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New Three-Drug cocktail aims to tackle Hard-to-Treat multiple myeloma
Disease control Not yet recruitingDespite advances in multiple myeloma (MM) therapy, patients continue to suffer from frequent relapses and treatment-resistant disease. Therefore, additional novel, safe, and effective therapies are needed to drive deeper and more prolonged responses for patients with RRMM. Mezig…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug cocktail aims to shrink cervical tumors before surgery
Disease control Not yet recruitingThis is a phase II, prospective, single-arm, multicenter, open-label study to evaluate the efficacy and safety of sacituzumab tirumotecan in combination with iparomlimab and tuvonralimab as neoadjuvant therapy in patients with locally advanced cervical cancer
Phase: PHASE2 • Sponsor: Zheng Min • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo therapy aims to tackle tough sarcomas
Disease control Not yet recruitingThe primary objective of this clinical trial is to evaluate the efficacy and safety of spatially fractionated radiotherapy combined with the PraG strategy in the treatment of soft tissue sarcoma (STS). The main questions it aims to answer are: 1. Can spatially fractionated radio…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can cannabis calm War's ghosts? new trial for vets with PTSD
Symptom relief Not yet recruitingThe rationale for the use of inhalational cannabis to potentially treat PTSD symptoms is based on the many reports of cannabis attenuating PTSD symptom expression among individuals with PTSD, including veterans. Study MJP2 is intended to build off MJP-1 through use of a larger sa…
Phase: PHASE2 • Sponsor: Multidisciplinary Association for Psychedelic Studies • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Heart shield: statin may guard against chemo damage in breast cancer
Prevention Not yet recruitingThis study, called "ROSUBREAST", is a multicenter, double-blind, randomized clinical trial evaluating whether rosuvastatin (20 mg daily) can protect the heart in women with breast cancer receiving anthracycline-based chemotherapy. A total of 400 participants will be randomly assi…
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Brain gene therapy aims to boost dopamine in young Parkinson's patients
Disease control Not yet recruitingThis study is looking at whether a gene therapy called AAV2-hAADC is safe and may help people with Parkinson's Disease. AAV2-hAADC is intended to increase the levels of dopamine in your brain. It contains a virus called adeno-associated virus 2 (AAV2) that has been modified to c…
Phase: PHASE1 • Sponsor: Krzysztof Bankiewicz • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a probiotic boost antidepressants? new trial tests Gut-Brain mood link
Disease control Recruiting nowThe goal of this clinical trial is to learn whether adding psychobiotics (a combination of Lactobacillus helveticus and Bifidobacterium longum) to standard antidepressant treatment works better than antidepressants alone for adults with major depressive disorder. The study will a…
Phase: NA • Sponsor: Dr Sadia yasir • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Liver cancer battle: which combo therapy wins?
Disease control Not yet recruitingAlthough the combination of transarterial chemoembolization (TACE) with PD-1 inhibitor plus lenvatinib has become a new standard, the therapeutic efficacy for unresectable hepatocellular carcinoma (uHCC) still requires improvement, as TACE remains limited for patients with multif…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
AI may help decide who gets immunotherapy after liver cancer surgery
Disease control Not yet recruitingEarly hepatocellular carcinoma (HCC) recurrence (driven by residual tumors) and late recurrence (driven by de novo tumors) exhibit distinct biological behaviors, suggesting differential therapeutic vulnerabilities. The beneficiaries of adjuvant PD-1 inhibitors (aPD-1) and their e…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for advanced colon cancer: drug combo trial launches
Disease control Not yet recruitingThis study is a phase Ib/II study to evaluate the efficacy, safety and tolerance of HLX43 combined with HLX07 or Serplulimab in patients with advanced or metastatic colorectal cancer failed or intolerance to standard first-line therapy
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New combo may offer better option for Hard-to-Treat colorectal cancer
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy and safety of fru+chemo as second-line therapy for patients with RAS-Mutant Metastatic Colorectal Cancer, especially when compared with the standard therapy BEV+chemo. The trial aims to provide this kind of patients wit…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for Hard-to-Treat breast cancer: drug duo targets rare mutation
Disease control Recruiting nowThe H3RAKLES trial would allow patients with a progressive metastatic breast cancer to have access to one more line of systemic therapy. Patients included in this trial will have already received at least two lines of chemotherapy (and potentially several lines of endocrine thera…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC